Lv65
2030 积分 2021-12-28 加入
First clinical evidence of repotrectinib efficacy in ROS1-rearranged NSCLC with a D2033N resistance mutation: case report
7小时前
已完结
The KRAS p.Ala146Thr mutation promotes the proliferation of colorectal cancer cells via CDK1-mediated ERK signaling
7小时前
已完结
Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair-deficient and/or POLE-mutant Endometrial Carcinomas with TP53 Mutation
9小时前
求助中
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR Mutations
9小时前
已完结
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
10小时前
已完结
Clinical outcome and prognosis of differentiated thyroid carcinoma with distant metastasis
12小时前
求助中
Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer
12小时前
求助中
Multi-omic-based classification for identifying optimal neoadjuvant treatment strategies for high-risk early-stage breast cancer
11天前
已完结
Similar trend in benefit of adjuvant platinum in lung cancer patients irrespective of epidermal growth factor receptor mutation status
14天前
已完结
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
14天前
已完结
皖公网安备34019202002308
